SCM
AEON.WS

Segantii Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Segantii Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,666
Closed -$118K – 209
2023
Q2 		$118K Hold
16,666
– – 0.01% 178
2023
Q1 		$169K Hold
16,666
– – 0.01% 293
2022
Q4 		$167K Hold
16,666
– – 0.01% 383
2022
Q3 		$164K Hold
16,666
– – ﹤0.01% 508
2022
Q2 		$163 Hold
16,666
– – ﹤0.01% 507
2022
Q1 		$163K Hold
16,666
– – ﹤0.01% 541
2021
Q4 		$162K Hold
16,666
– – 0.01% 529
2021
Q3 		$162K Buy
+16,666
New +$12.2K 0.01% 451

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Segantii Capital Management's AEON.WS Position: Q3 2023 in Review

Segantii Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 16,666 shares — an estimated $118K sold.

Segantii Capital Management first reported a position in AEON.WS in Q3 2021 and held it in 8 quarters. The position peaked at $169K in Q1 2023. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

  • Segantii Capital Management reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
  • Segantii Capital Management sold 16,666 AEON Biopharma Inc shares in Q3 2023, an estimated $118K.
  • Segantii Capital Management first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 8 quarters.
  • Segantii Capital Management's AEON Biopharma Inc position peaked at $169K in Q1 2023.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on Segantii Capital Management's 13F filing for Q3 2023, filed 7 Nov 2023.